![Article of the day, September 3rd, suggested by the Immune Oncology Research Institute](https://oncodaily.com/pub/uploads/2024/09/sept-3.jpg)
Article of the day, September 3rd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn:
“Article of the day! Suggest by the Immune Oncology Research Institute.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
Authors: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Tom Ferguson, Stefan N. Symeonides, Jaroslav Hajek, Yen-Hwa Chang, Jae-Lyun Lee, Naveed Sarwar, Naomi B. Haas, Howard Gurney, Piotr Sawrycki, Mauricio Mahave, Marine Gross-Goupil, Tian Zhang, John M. Burke, Gurjyot Doshi, Bohuslav Melichar, Evgeniy Kopyltsov, Ajjai Alva, Stephane Oudard, Delphine Topart, Hans Hammers, Hiroshi Kitamura, David F. McDermott, Adriano Silva, Eric Winquist, Jerry Cornell, Aymen Elfiky, Joseph E. Burgents, Rodolfo F. Perini, Thomas Powles.
Author Affiliations: Dana-Farber Cancer Institute ,Poznan University of Medical Sciences ,Samsung Medical Center ,Beatson Oncology Centre ,Imperial College Healthcare NHS Trust ,Barts Cancer Institute (Queen Mary University of London) ,Fiona Stanley Hospital ,Penn Medicine, University of Pennsylvania Health System ,CHU de Bordeaux ,Rocky Mountain Cancer Centers ,et al.
Source: Immune Oncology Research Institute/LinkedIn
Immune Oncology Research Institute (IMMONC), established in 2022, is a non-profit, independent, patient-centered research institute. The mission of IMMONC is to advance the cancer knowledge and care through breakthrough scientific research, to integrate innovative immune-oncology therapies into the clinical practice for different types of cancers, to generate and collect clinical data for the identification of new therapeutic targets, developing predictive models and optimizing patient outcomes, to increase the availability and accessibility of those discoveries for the cancer patients, to create a world-class professional environment, to attract the brightest minds in cancer field and to train the next generation researchers.
Other posts featuring Immune Oncology Research Institute on OncoDaily.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023